Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Incidental Detection of a Rare Pediatric High-Grade Fibrosarcoma in a Post-traumatic Setting: The Conundrum of Intra-Abdominal Hematoma versus Neoplasia. | Case Rep Radiol | 2023 | 38089103 | PubTator, text mining | PubMed |
| High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity. | Indian J Pathol Microbiol | 2023 | 38084541 | PubTator, text mining | PubMed |
| "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. | Acta Neuropathol | 2023 | 38079020 | PubTator, text mining | PubMed |
| Venetoclax combined with hypomethylating agents and the CAG regimen in relapsed/refractory AML: a single-center clinical trial. | Front Immunol | 2023 | 38054008 | PubTator, text mining | PubMed |
| [Mutation pedigree and treatment selection of Erdheim-Chester disease]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049347 | PubTator, text mining | PubMed |
| [Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia (not APL) (2023)]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049312 | PubTator, text mining | PubMed |
| Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders. | Haematologica | 2023 | 38037802 | PubTator, text mining | PubMed |
| Tumor-suppressive functions of protein lysine methyltransferases. | Exp Mol Med | 2023 | 38036730 | PubTator, text mining | PubMed |
| Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors. | Nat Commun | 2023 | 38036539 | PubTator, text mining | PubMed |
| Role of immunohistochemistry in diagnosing round-cell tumours affecting the oral and maxillofacial regions. | J Oral Maxillofac Pathol | 2023 | 38033945 | PubTator, text mining | PubMed |
| CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study. | Ther Adv Med Oncol | 2023 | 38028143 | PubTator, text mining | PubMed |
| Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations. | Open Med (Wars) | 2023 | 38025540 | PubTator, text mining | PubMed |
| Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma. | Neurooncol Adv | 2023 | 38024240 | PubTator, text mining | PubMed |
| Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation. | Pharmgenomics Pers Med | 2023 | 38023823 | PubTator, text mining | PubMed |
| Case Report: A novel TP53 mutation in a patient with quadruple wild-type gastrointestinal stromal tumor. | Front Oncol | 2023 | 38023229 | PubTator, text mining | PubMed |
| The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas. | Front Oncol | 2023 | 38023160 | PubTator, text mining | PubMed |
| A Case of ALK-Positive Anaplastic Large Cell Lymphoma of the Male Breast. | Int Med Case Rep J | 2023 | 38020577 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| An encyclopedia of enhancer-gene regulatory interactions in the human genome. | bioRxiv | 2023 | 38014075 | PubTator, text mining | PubMed |
| Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study. | Blood Cancer J | 2023 | 38012154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=18